Brown S R, Klinger H, O'Brien P Q. "一种哌仑他韦杂质6的合成方法" [P]. US Patent, US 11377662 B2, 2024-09-27.
发明人王建平,杨光,郑宇鹏. "Method for the Synthesis of Pibrentasvir impurity 6" [P]. 中国发明专利, 专利号 CN 116783023 B, 授权公告日 2025-02-28.
Williams B T, Fischer A B, Brown S R. "A Process for Preparing High-Purity Pibrentasvir impurity 6" [P]. US Patent, US 9218122 B2, 2016-03-22.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 哌仑他韦杂质6 in Pharmaceutical Formulations". Chromatographia, 2019, 1187, (12), 1900-1925.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 哌仑他韦杂质6 as an Impurity". J. Sep. Sci., 2024, 1494, (2), 3986-4013.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Pibrentasvir impurity 6 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2012, 391, 1964-1971.